Selectivity of felodipine for depolarized ventricular myocytes: A study at the single-cell level

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 355-363

  Kohmoto, Osami ^a   Shimizu, Tatsuya ^a   Sugishita, Kazuro ^a   Kinugawa, Koh ichiro ^a   Takahashi, Toshiyuki ^a   Serizawa, Takashi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ca2+ channel, L type; E C (excitation contraction) coupling; Felodipine; Ventricular cell, guinea pig; Voltage dependent block

Indexed keywords

CALCIUM CHANNEL; FELODIPINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; EXCITATION CONTRACTION COUPLING; FEMALE; GUINEA PIG; HEART MUSCLE CELL; HEART VENTRICLE WALL; MEMBRANE STEADY POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL MOVEMENT; CELL SIZE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; FELODIPINE; FEMALE; GUINEA PIGS; HEART VENTRICLES; MEMBRANE POTENTIALS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PATCH-CLAMP TECHNIQUES;

EID: 0031031850     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00867-9     Document Type: Article

References (32)

1. Bean, B.P., 1984, Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state, Proc. Natl. Acad. Sci. USA 81, 6388.
2. Burges, R.A., D.G. Gardiner, M. Gwilt, A.J. Higgins, K.J. Blackburn, S.F. Campbell, P.E. Cross and J.K. Stubbs, 1987, Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors, J. Cardiovasc. Pharmacol. 9, 110.
3. Cheng, C.P., T. Noda, M. Nordlander, M. Ohno and W.C. Little, 1994, Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance, J. Pharmacol. Exp. Ther. 268, 1232.
4. Cohn, J.N., D.G. Archibald, S. Ziesche, J.A. Franciosa, W.E. Harston, F.E. Tristani, W.B. Dunkman, W. Jacobs, G.S. Francis, K.H. Flohr, S. Goldman, F.R. Cobb, P.M. Shah, R. Saunders, R.D. Fletchter, H.S. Loeb and C.V. Hughes, 1986, Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study, New Engl. J. Med. 314, 1547.
5. Cohn, J.N., G. Johnson, S. Ziesche, F. Cobb, G. Francis, F. Tristani, R. Smith, W.B. Dunkman, H. Loeb, M. Wong, G. Bhat, S. Goldman, R.D. Fletcher, J. Doherty, C.V. Hughes, P. Carson, G. Cintron, R. Shabetai and C. Haakenson, 1991, A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure, New Engl. J. Med. 325, 303.
6. 2+ with indo-1 in feline myocytes, in: Biology of Isolated Adult Cardiac Myocytes, ed. W. Clark (Elsevier, New York, NY) p. 187.
7. Elkayam, U., J. Amin, A. Mehra, J. Vasquez, L. Weber and S.H. Rahimtoola, 1990, A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide-dinitrate and their combination in the treatment of chronic congestive heart failure, Circulation 82, 1954.
8. Fleckenstein, A., 1983, Calcium Antagonism in Heart and Smooth Muscle. Experimental Facts and Therapeutic Prospects (John Wiley, New York, NY).
9. Godfraind, T., N. Morel and M. Wibo, 1988, Tissue selectivity of dihydropyridine-type calcium antagonists in human isolated tissues, Trends Pharmacol. Sci. 9, 37.
10. 3H)nitrendipine to rat cardiac myocytes, Circ. Res. 56, 576.
11. 2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260, 3440.
12. Herzig, S., H. Lüllmann and H. Sieg, 1992, Frequency- and potential-dependency of the negative inotropic action of various dihydropyridine and non-dihydropyridine calcium antagonists, Pharmacol. Toxicol. 71, 229.
13. Hughes, A.D. and S. Wijetunge, 1993, The action of amlodipine on voltage-operated calcium channels in vascular smooth muscle, Br. J. Pharmacol. 109, 120.
14. Jezek, V., J. Jezkova, A. Michaljanic, P. Niederle and R. Feuereisl, 1990, Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure, Eur. Heart J. 11, 1059.
15. Kass, R.S., J.P. Arena and S. Chin, 1991, Block of L-type calcium channels by charged dihydropyridines, J. Gen. Physiol. 98, 63.
16. 2+ fluxes, and contraction in ventricular myocytes, Circ. Res. 66, 622.
17. Kohmoto, O., A.J. Levi and J.H.B Bridge, 1994, Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells, Circ. Res. 74, 550.
18. LeBlanc, N. and J.R. Hume, 1990, Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum, Science 248, 372.
19. Littler, W.A. and D.J. Sheridan, 1995, Placebo controlled trial of felodipine in patients with mild to moderate heart failure, U.K. Study Group, Br. Heart. J. 73, 428.
20. Ljung, B., A. Kjellstedt and B. Oreback, 1987, Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations, J. Cardiovasc. Pharmacol. 10 (Suppl. 1), S34.
21. Lumley, P. and M.J. Robertson, 1987, Can differential calcium channel blocker potency in cardiac muscle be explained by the modulated receptor hypothesis?, Br. J. Pharmacol. 92, 769P.
22. Nabauer, M., D.J. Beuckelmann and E. Erdmann, 1993, Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure, Circ. Res. 73, 386.
23. Nelson, M.T. and J.F. Worley, 1989, Dihydropyridine inhibition of single calcium channels and contraction in rabbit meseteric artery depends on voltage, J. Physiol. (London) 412, 65.
24. Packer, M., C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuber, D. Frid, J.H. Wertheimer, A.B. Cropp and D.L. DeMets, 1996, Effect of amlodipine on morbidity and mortality in severe chronic heart failure, New Engl. J. Med. 335, 1107.
25. Peeters, G.A., V. Hlady, J.H.B. Bridge and W.H. Barry, 1987, Simultaneous measurement of calcium transients and motion in cultured heart cells, Am. J. Physiol. 253, H1400.
26. Pérez-Vizcaíno, F., J. Tamargo, R.P. Hof and U.T. Rüegg, 1993, Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level, J. Cardiovasc. Pharmacol. 22, 768.
27. Sanguinetti, M. and R.S. Kass, 1984, Voltage-dependent block of calcium channel current in the calf Purkinje fiber by dihydropyridine calcium channel blockers, Circ. Res. 55, 336.
28. Steadman, B.W., K.B. Moore, K.W. Spitzer and J.H.B Bridge, 1988, A video system for measuring motion in contracting heart cells, IEEE Trans. Biomed. Eng. 35, 264.
29. Sun, J. and D.J. Triggle, 1995, Calcium channel antagonists: cardiovascular selectivity of action, J. Pharmacol. Exp. Ther. 274, 419.
30. Tan, L.B., R.G. Murray and W.A. Littler, 1987, Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects, Br. Heart J. 58, 122.
31. Welling, A., Y.W. Kwan, E. Boss, V. Flokerzi, F. Hofman and R.S. Kass, 1993, Subunit-dependent modulation of recombinant L-type Ca channels. Molecular basis of dihydropyridine tissue selectivity, Circ. Res. 73, 974.
32. Wibo, M., 1989, Mode of action of calcium antagonists: voltage dependence and kinetics of drug-receptor interaction, Pharmacol. Toxicol. 65, 1.